theranosfilm / independent analysis

The central question / present versus future

Theranos claims: working now or possible later?

What exactly was claimed, to whom, when—and what could the system demonstrate then?

Edited by the Theranos Film project · Briar assisted · . Editorial draft; not independently fact-checked. About this independent project · Corrections and review history.

A useful ambition is not a working capability

“We intend to develop” and “our system runs” make different representations. Neither tense alone settles a fraud allegation: the full communication, materiality, knowledge and relevant legal findings also matter.

This comparison separates actual source wording from our paraphrase. It does not quote the film without a checked transcript, and it does not assume every investor saw the same material.

Surviving investor presentation

Exhibit version; delivery date to an individual investor not established here

Short excerpt: Trial Exhibit 3696, PDF page 3

runs comprehensive blood tests from a finger-stick

What this means
The verb runs presents a capability. The excerpt is not expressly framed as a future research objective.
Evidence to test
Identify device version, test menu, sample volume, off-device work, accuracy and qualifications accompanying this version.
What it does not establish
The slide alone proves neither capability nor that a particular investor received it. It does not establish every oral qualification or an individual's knowledge and intent.
Sources and inspection limits
  • United States v Holmes: trial Exhibit 3696 · Original source

    Contemporaneous presentation / trial exhibit · PDF page 3; page 8 reviewed earlier

    Page-level inspection, not the full delivery history. Wording is evidence of a representation, not demonstrated capability, authorship, delivery to a particular investor or all accompanying qualifications.

Challenge or correct this entry · Curated record revision history

Contemporaneous representation versus alleged operation

14 March 2018 enforcement announcement, describing earlier conduct

Editorial paraphrase of civil allegations; not a quotation

The SEC alleged a mismatch between represented proprietary capability and the use of third-party analyzers for most patient testing.

What this means
The material question is what the represented service could actually deliver at the investment date, not whether the general research ambition was worthwhile.
Evidence to test
Match an individual representation to dated demonstrations, validation, internal limitations and investor communications.
What it does not establish
Civil allegations and settlement terms are not criminal findings. The DOJ's later account and count-by-count verdict must be read separately.
Sources and inspection limits
  • SEC announcement 2018-41 · Original source

    Regulator account of allegations and settlement · Opening paragraphs; technology, revenue and resolution

    Announcement inspected on 21 November 2026. A civil settlement announcement is not a criminal verdict or a complete accounting ledger.

  • SEC complaint against Holmes and Theranos, 14 March 2018 · Original source

    Civil allegations · Paragraphs 1–5 and 48–51; retain full document context

    Selected passages; not a complete exhibit audit. Allegations must not be relabelled as judicial findings; each investor's actual information requires separate evidence.

  • DOJ: Holmes investor-fraud verdict, 4 January 2022 · Original source

    Prosecution account of trial and mixed verdict · Verdict summary and account of trial evidence

    Selected verdict and evidence passages inspected. Read the verdict count by count. This is not the complete trial record or a finding that every allegation was proven.

Challenge or correct this entry · Curated record revision history

Later platform account

2016 company technology announcement; later film discussion needs timestamps

Editorial distinction; not a quotation from the film or company

A proposed integrated platform is a different claim from validated earlier delivery of a full testing service.

What this means
A later architecture or development plan cannot retrospectively validate a prior product or investor representation. Conversely, failure of a prior product does not prove every later proposal scientifically impossible.
Evidence to test
Separate prototype operation, assay-specific validation, clinical use, menu breadth and commercial reliability for each date and version.
What it does not establish
The company announcement is not independent performance evidence. The film's exact wording and surrounding question remain unverified.
Sources and inspection limits

Challenge or correct this entry · Curated record revision history

What would an investor normally need to see?

There is no universal demonstration or single technical document that every private investment must include. A record of money invested does not show what was demonstrated or verified. Analyse the actual transaction, its disclosures and applicable obligations.

Match a representation to the proof it needs
RepresentationRelevant evidence
A working prototypeDefined device and protocol; repeatable runs; full failures and off-device steps disclosed.
Reliable clinical testsAssay-specific validation for the stated sample, range, use and population.
A broad automated platformMenu-level performance, integration, throughput, controls, staffing and realistic operational reliability.
A future opportunityExplicit milestones, unresolved risks, credible resources and forecasts distinguishable from achieved performance.

Bring the film back into the comparison

Record the full question and answer, film edition and timestamp. Determine whether the speaker is describing the earlier product, later architecture or an ambition. Then ask whether that account addresses the original representation or changes its meaning.

Investor chronology · Original claim record · Technical explanation

Follow the Peterson investor evidence chain · Inspect the first granted-claim chart.